GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, …
GARDASIL 9 is a vaccine indicated in females 9 through 45 years of age for the prevention of cervical, vulvar, vaginal, anal, oropharyngeal and other head and neck cancers caused by …
FDA Approves Merck's HPV Vaccine, GARDASIL®9, to Prevent …
Dec 11, 2014 · GARDASIL 9 includes the greatest number of HPV types in any available HPV vaccine Merck (NYSE:MRK), known as MSD outside the United States and Canada, …
Merck Issues Statement on GARDASIL® Litigation
RAHWAY, N.J., Jan. 28, 2025 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today reaffirmed its commitment to defending the safety and efficacy of its …
FDA Approves Merck’s GARDASIL 9 for the Prevention of Certain …
Jun 12, 2020 · GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) Now Approved for the Prevention of HPV-Related Cervical, Vaginal, Vulvar, Anal, Oropharyngeal …
Gardasil | FDA - U.S. Food and Drug Administration
Tradename: Gardasil Manufacturer: Merck & Co., Inc. Indications: Prevention of vulvar and vaginal cancer
GARDASIL 9 | FDA - U.S. Food and Drug Administration
Mar 15, 2024 · Product approval information for Human Papillomavirus 9-valent Vaccine, Recombinant also known as Gardasil 9.
GARDASIL® is a vaccine indicated in girls and women 9 through26 years of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types included in …
Efficacy of GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)
GARDASIL 9 is indicated in males 9 through 45 years of age for the prevention of anal, oropharyngeal and other head and neck cancers caused by HPV Types 16, 18, 31, 33, 45, 52, …
GARDASIL®9, Human Papillomavirus 9 -valent Vaccine, Recombinant, is a vaccine indicated in individuals 9 through 45 years of age for the prevention of infection caused by the Human …
Merck’s $8 Billion Cancer Vaccine Faces First US Jury Trial
Jan 27, 2025 · Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the …